Document is current
Any future updates will be listed below
-
Authors
Wang, Xuefeng https://orcid.org/0000-0001-5775-408X
Muzaffar, Jameel
Kirtane, Kedar https://orcid.org/0000-0003-1302-9577
Song, Feifei
Johnson, Matthew
Schell, Michael J
Li, Jiannong
Yoder, Sean J
Conejo-Garcia, Jose R
Guevara-Patino, Jose A
Bonomi, Marcelo
Bhateja, Priyanka
Rocco, James W
Steuer, Conor E
Saba, Nabil F https://orcid.org/0000-0003-4972-1477
Chung, Christine H https://orcid.org/0000-0001-5199-4306
-
Clinical Trials BETA
Clinical trials referenced in this document:
nct03370276 at ClinicalTrials.govnct03370276 at ClinicalTrials.govDocuments that mention this clinical trial
T cell repertoire in peripheral blood as a potential biomarker for predicting response to concurrent cetuximab and nivolumab in head and neck squamous cell carcinoma
https://doi.org/10.1136/jitc-2022-004512
Documents that mention this clinical trial
T cell repertoire in peripheral blood as a potential biomarker for predicting response to concurrent cetuximab and nivolumab in head and neck squamous cell carcinoma
https://doi.org/10.1136/jitc-2022-004512
-
Funding
Funding for this research was provided by:
National Institute of Dental and Craniofacial Research (R01DE030493)
James and Esther King Biomedical Research Grant (7JK02)
National Cancer Institute (P30-CA076292)
- License Information
